Humanscape

Humanscape

HUM
$0.067505919%9.80

Key Metrics

Price$0.067505919
Real Volume (24H)$14,669,099.9
Marketcap$69,850,688.12
Fully Diluted ValuationN/A
ATH$0.994652
ATH Date11/18/2021, 5:20:53 AM
ATL$0.00006688
ATL Date1/27/2019, 3:00:00 AM
Circulating SupplyN/A
Total Supply1.1B
Popularity Rank534
Chart
What is Humanscape?

Humanscape (HUM) is a blockchain-based patient network that aims to build a harmonious ecosystem for individuals to live and thrive in. The network has developed several healthcare projects using advanced technologies to make healthcare more accessible and efficient for patients.

One of the key projects on Humanscape is Rarenote, a platform that provides patients with information on rare diseases and updates on clinical studies and treatments. Another project is Clinical Trials Korea, a platform that matches patients with new opportunities for clinical trials and aims to reduce economic losses caused by delays in the trials. Additionally, Humanscape has developed Mommy Talk, a parenting and pregnancy app that allows patients to easily access ultrasound images and other medical records during pregnancy, and connect with other parents to discuss parenting topics.

To facilitate the operations of the Humanscape blockchain network, the platform has introduced its own cryptocurrency, the HUM token. The HUM token is used as a medium of exchange on the network and is used to control stakeholders' actions. It is also used for the development of the Humanscape community. Users can acquire the tokens by purchasing them on decentralized exchanges or by receiving them from other users on the network.

Humanscape was founded in 2016 by Min-hoo Chang, the current CEO of the organization. The foundation team was formed earlier in 2013. The total supply of HUM tokens is capped at 125 billion.

Humanscape's vision is to create a decentralized patient network that empowers individuals to take control of their own health data. By using blockchain technology, Humanscape aims to bring together patients, researchers, and healthcare providers to share information and collaborate on finding new treatments and cures for diseases.

One of the key features of Humanscape is the RareNote platform, which provides patients with information on rare diseases and updates on clinical studies and treatments. This platform aims to empower patients by giving them access to the latest research and information, and by connecting them with other patients who have similar conditions.

Another important aspect of Humanscape is the Clinical Trials Korea platform, which helps patients find new opportunities for clinical trials by matching service requests. This platform aims to reduce the economic losses caused by delays in clinical trials and to make it easier for patients to participate in research that could lead to new treatments and cures.

Humanscape also offers a range of other healthcare-related services, including the Mommy Talk app, which connects parents and provides them with easy access to ultrasound images and other important medical records during pregnancy.

The Humanscape community is at the heart of the network, and the HUM token is used to control stakeholders’ actions and to develop the community. Users can acquire HUM tokens by purchasing them from decentralized exchanges or by receiving them as transfers from other users on the network.

Humanscape was founded in 2016 by Min-hoo Chang and has a team of experienced professionals with backgrounds in healthcare, blockchain, and technology. The organization's mission is to empower patients and to make healthcare more accessible and efficient.

Disclaimer

The investment information, comments, and recommendations provided here do not fall under the scope of investment consulting. Therefore, making an investment decision based solely on the information and comments provided here may not yield results that meet your expectations.

Stay ahead of the competition by accessing high-quality data, advanced tools, and expert research.

Try for Free

Top Assets

AssetPrice24HMcap
Loading...

We use cookies for personalization, social media, and analytics, and share usage data with partners.